Structured to conquer: transport across the Plasmodium parasitophorous vacuole.


Journal

Current opinion in microbiology
ISSN: 1879-0364
Titre abrégé: Curr Opin Microbiol
Pays: England
ID NLM: 9815056

Informations de publication

Date de publication:
10 2021
Historique:
received: 31 03 2021
revised: 13 07 2021
accepted: 19 07 2021
pubmed: 11 8 2021
medline: 4 10 2022
entrez: 10 8 2021
Statut: ppublish

Résumé

During the vertebrate stage of the Plasmodium life cycle, obligate intracellular malaria parasites establish a vacuolar niche for replication, first within host hepatocytes at the pre-patent liver-stage and subsequently in erythrocytes during the pathogenic blood-stage. Survival in this protective microenvironment requires diverse transport mechanisms that enable the parasite to transcend the vacuolar barrier. Effector proteins exported out of the vacuole modify the erythrocyte membrane, increasing access to serum nutrients which then cross the vacuole membrane through a nutrient-permeable channel, supporting rapid parasite growth. This review highlights the most recent insights into the organization of the parasite vacuole to facilitate the solute, lipid and effector protein trafficking that establishes a nutrition pipeline in the terminally differentiated, organelle-free red blood cell.

Identifiants

pubmed: 34375857
pii: S1369-5274(21)00097-7
doi: 10.1016/j.mib.2021.07.010
pmc: PMC8463430
mid: NIHMS1727806
pii:
doi:

Substances chimiques

Protozoan Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

181-188

Subventions

Organisme : NHLBI NIH HHS
ID : K99 HL133453
Pays : United States
Organisme : NHLBI NIH HHS
ID : R00 HL133453
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Références

Elife. 2017 Mar 02;6:
pubmed: 28252384
Cell Host Microbe. 2015 May 13;17(5):642-52
pubmed: 25974303
PLoS Pathog. 2020 Feb 18;16(2):e1008363
pubmed: 32069335
Cell. 2011 May 27;145(5):665-77
pubmed: 21620134
Cell Microbiol. 2017 May;19(5):
pubmed: 27892646
mBio. 2019 Jun 4;10(3):
pubmed: 31164473
Nat Microbiol. 2018 Oct;3(10):1090-1098
pubmed: 30150733
Proc Natl Acad Sci U S A. 2021 Aug 31;118(35):
pubmed: 34446549
Elife. 2017 Feb 21;6:
pubmed: 28221136
Nat Commun. 2015 Mar 31;6:6721
pubmed: 25823844
Traffic. 2018 Aug;19(8):605-623
pubmed: 29696751
Mol Biochem Parasitol. 2002 Feb;119(2):249-56
pubmed: 11814576
Cell Microbiol. 2019 Apr;21(4):e13009
pubmed: 30656810
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2045-9
pubmed: 9050902
PLoS Pathog. 2016 May 11;12(5):e1005618
pubmed: 27168322
Nat Commun. 2021 Jun 15;12(1):3620
pubmed: 34131147
PLoS Biol. 2019 Sep 30;17(9):e3000473
pubmed: 31568532
Eukaryot Cell. 2015 Apr;14(4):415-26
pubmed: 25724884
Cell Microbiol. 2020 May;22(5):e13168
pubmed: 31990132
Cell Host Microbe. 2015 Sep 9;18(3):371-81
pubmed: 26355219
Elife. 2017 Mar 02;6:
pubmed: 28252383
Elife. 2019 Mar 19;8:
pubmed: 30888318
mBio. 2020 Mar 17;11(2):
pubmed: 32184257
Nature. 2014 Jul 31;511(7511):592-5
pubmed: 25043010
Nat Microbiol. 2018 Sep;3(9):1010-1022
pubmed: 30127496
Nat Commun. 2017 Jul 10;8:16044
pubmed: 28691708
Cell Microbiol. 2016 Mar;18(3):399-412
pubmed: 26347246
Nat Rev Microbiol. 2016 Aug;14(8):494-507
pubmed: 27374802
mBio. 2020 Sep 8;11(5):
pubmed: 32900800
Mol Biochem Parasitol. 2009 Sep;167(1):48-53
pubmed: 19393693
Nature. 2014 Jul 31;511(7511):587-91
pubmed: 25043043
PLoS Pathog. 2021 Feb 18;17(2):e1009259
pubmed: 33600495
Cell Microbiol. 2021 Aug;23(8):e13332
pubmed: 33774908
Int J Med Microbiol. 2018 Jan;308(1):107-117
pubmed: 28964681
PLoS Pathog. 2021 Apr 1;17(4):e1009394
pubmed: 33793667
Mol Microbiol. 2006 Feb;59(3):779-94
pubmed: 16420351
Nature. 2018 Sep;561(7721):70-75
pubmed: 30150771
Mol Biochem Parasitol. 1983 Jun;8(2):177-90
pubmed: 6348537
Nat Commun. 2020 Jul 30;11(1):3825
pubmed: 32732874
Elife. 2021 Jan 04;10:
pubmed: 33393463
mBio. 2019 Jul 9;10(4):
pubmed: 31289187
Cell Chem Biol. 2020 Jun 18;27(6):719-727.e5
pubmed: 32330444
Nat Rev Microbiol. 2017 Aug;15(8):479-491
pubmed: 28603279
J Biochem. 2019 Mar 1;165(3):239-248
pubmed: 30476118
Nature. 1993 Apr 15;362(6421):643-6
pubmed: 7681937
Nature. 2000 Aug 31;406(6799):1001-5
pubmed: 10984055
Science. 2020 Jan 3;367(6473):51-59
pubmed: 31896710
J Biol Chem. 2013 Nov 1;288(44):31971-83
pubmed: 24043620
Sci Rep. 2015 Jul 29;5:12532
pubmed: 26219962
Nat Commun. 2020 Nov 6;11(1):5654
pubmed: 33159090
Nat Rev Microbiol. 2020 Jul;18(7):379-391
pubmed: 31980807
Biochem Biophys Res Commun. 2017 Jan 22;482(4):700-705
pubmed: 27865834
J Biol Chem. 2003 Feb 21;278(8):6532-42
pubmed: 12456681
PLoS Pathog. 2018 May 18;14(5):e1007057
pubmed: 29775485

Auteurs

Matthias Garten (M)

Section on Integrative Biophysics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20892, USA. Electronic address: matthias.garten@nih.gov.

Josh R Beck (JR)

Department of Biomedical Sciences, Iowa State University, Ames, IA, 50011, USA. Electronic address: jrbeck@iastate.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH